Cryomass Technologies Inc. specializes in the development of innovative cryogenic technology for the extraction of bioactive compounds from plant materials, primarily targeting the cannabis and hemp industries. The company operates in North America, leveraging its proprietary extraction processes that boast a 100% gross margin due to low operational costs and high product value.
HealthcareDrug Manufacturers - Specialty & Generichigh - The company has high fixed costs associated with its technology and equipment, but once operational, it can scale efficiently with minimal incremental costs.